You searched for "market"

4080 results found

Young CEORL-HNS: empowering the future of otorhinolaryngology

Young CEORL-HNS is a subgroup within CEORL-HNS which encompasses new specialists in ENT within training and up to the first decade or so as an accredited specialist. Giuditta Mannelli is the current president and is a head and neck surgeon...

Jameel Muzaffar, Anne Schilder and James O’Hara

In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...

Lyric 24/7 hearing: could it help those with tinnitus?

About Lyric Hearing Since its launch in 2008, Lyric represents the first and only device of its kind establishing a new category of hearing solution: 24/7 extended wear. Lyric is placed several millimetres within the ear canal, near the tympanic...

Branchio Oto Renal syndrome

Branchio Oto Renal Syndrome (BOR) is an autosomal dominant disorder with branchial, otologic and renal manifestations. The presence of clinical signs varies among and within affected families. Three causative genes for BOR syndrome have been reported thus far: EYA1, SIX1...

Three is not a crowd! Involving family members in audiology appointments

Family members currently have minimal involvement in the appointment. Image by Caitlin Grenness. Hearing loss in older adults not only affects the patients themselves, but also their family members. This article outlines the findings of recent research into how family...

Audiovestibular findings in children with enlarged vestibular aqueduct

Enlarged vestibular aqueduct is reported to affect up to 15% of the paediatric population with sensorineural hearing loss. Devin McCaslin and Bridget Smith provide an up-to-date overview of the mechanisms and clinical symptoms underlying the condition and share some of...

User perspectives of online audiological rehabilitation programmes

Recent research shows that online audiological rehabilitation programmes have the potential to improve the quality of life of hearing aid users. However, there are still areas that need need improvement. Elisabet Thorén discusses some of the problems people face when...

The future of inner ear drug delivery

The techniques for delivering drugs to the inner ear system are evolving. Jeffrey Harris considers the myths, the facts and the potential for drug delivery innovations and how they can improve tomorrow’s hearing outcomes. The inner ear’s delicate membranous structure,...

Health related quality of life measures as outcome parameters in middle ear diseases

Surely the only outcome needed for post-surgical ears is a better PTA? Marcus Neudert argues there should be more to it than that. To draw a comprehensive picture of the disease-associated restrictions in patients with chronic otitis media, audiometric outcome...

Hidden hearing loss in humans

Awareness of cochlear synaptopathy (‘hidden hearing loss’) is growing. Chris Plack gives us an introduction to the condition, defining it and reviewing recent research in humans and animals with respect to noise exposure. The main cause of hearing loss is...

What’s hidden in hidden hearing loss?

In order to truly understand the many key aspects of acquired sensorineural hearing loss, the role of cochlear synaptopathy or ‘hidden hearing loss’ must be considered. Dan Guo and Sharon Kujawa review and summarise what we know to date, including...

Hidden hearing loss in humans: cochlear synaptopathy is superseded by cognitive effects when listening to speech in noise

Elizabeth Beach presents an overview of the recent research being undertaken at the National Acoustic Laboratories on speech in noise and its relationship to cochlear synaptopathy. Our team at the National Acoustic Laboratories (NAL) has been investigating hidden hearing loss...